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Introduction
Acute lung injury (ALI) is a devastating clinical condition,
characterised by acute inflammation that often proceeds
to overt pulmonary fibrosis. Basal bone morphogenetic
protein (BMP) signalling is essential for normal pulmonary
homeostasis. The BMP antagonist gremlin has previously
been shown to be increased in hypoxic lung disease,
reduce BMP signalling and thus contribute directly to
lung damage [1]. BMP antagonsists also play important
roles in fibrotic diseases [2].
Objectives
The aim of this study was to investigate the expresison of
BMP accessory proteins in an animal model of ALI and
assess any associated changes in BMP signalling.
Methods
Acute lung injury was induced in adult mice by intra-
tracheal instillation of bleomycin (1U/kg); saline was
instilled in control animals. Fourteen days post inocula-
tion, animals were anaesthetised, killed and their lungs
removed and snap frozen for later analysis of RNA and
protein. Lungs from separate groups were isolated, fixed,
and wax embedded for histological and immunohisto-
chemical analysis.
Results
Bleomycin treated lungs showed characteristic structural
changes and patchy inflammation. Gremlin, follistatin, fol-
listatin like 1, follistatin like 3, BMPER and noggin mRNA
expression was increased, the expression of BAMBI and
NOV was reduced. MGP, KCP, lefty and chordin were
unchanged. Expresion of Follistatin like 1, BAMBI and
noggin protein was increased. Consistent with attentuated
BMP signalling, BMP-2 and phospho-smad 1/5/8 was
reduced.
Conclusions
These data demonstrate that BMP antagonists are altered
in bleomycin injured lungs and associated with reduced
BMP signalling.
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